StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Nagaraj Shetty, HDFC Securities

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byNagaraj Shetty, HDFC SecuritiesHorizon: NA (inferred Swing (≤2wk))4 Nov 2026via ET Now

Entry₹2,538Inferred
Target₹2,550
Total upside +0.47% (call closed)
Stop lossNot given
Exit₹2,5506 Nov 2026, 10:00 am
Target hit+0.47%0.00%upside left
Follow Nagaraj Shetty for new calls(37% target hit, 75 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 1 active Swing call on GLENMARKSee 203 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Nov, 9:55 pm IST
4 supporting2 neutral1 opposing
Supports the BUY call (4)

Glenmark Pharma shares will react to better-than-expected US sales in Q2, 14% growth in India biz

NewsCnbc-Tv18·6 Nov · today

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·3 Nov · 2d ago

Glenmark stock: US distribution hub expands supply chain

NewsGoogle News·30 Oct · 1w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·23 Sept · 1mo ago

Neutral / worth noting (2)

Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·5 Nov · today

(opens in new tab)

Ichnos Glenmark Innovation will present updated clinical data for ISB 2001 at the 68th ASH Annual Meeting.

BSE · Company Update·4 Nov · yesterday

(opens in new tab)
Weighs against the BUY call (1)

Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr

NewsEt-Markets·5 Nov · today

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Nagaraj Shetty, HDFC Securities

Every call and its outcome